BridgeMD
Tests treatment safety and results for Glaucoma
Official title Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery
ClinicalTrials.gov ID: NCT06760169
What this study is testing
- What it's testing
- Glaucoma is an irreversible optic neuropathy. It is the second most common cause of blindness worldwide.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients ≥ 18 years of age who agree to take part in the study and have signed an informed consent form
- Visually significant cataract with indication for surgery
- Primary open-angle glaucoma, or secondary open-angle glaucoma (pseudoexfoliative glaucoma or pigmentary glaucoma) with indication for cataract...
- Open iridocorneal angle (Shaffer classification grade 2-4)
- Early to moderate glaucoma (advanced glaucoma, with MD from VFs worse than -12dB, will be excluded)
You likely can't join if
- Presence of severe systemic pathologies 2024-A01891-46\_Protocol\_V6\_21112024\_Elios Page 20 / 58
- Pregnant or breastfeeding women
- \<18 years of age
- Presence of other ophthalmological pathologies (except cataracts), and exclusion of severe dry eye.
- History of intraocular surgery, trauma, or conjunctival scarring in the quadrant intended for surgery
- Visual acuity worse than "counting fingers".
See the full eligibility criteria
- Patients ≥ 18 years of age who agree to take part in the study and have signed an informed consent form
- Visually significant cataract with indication for surgery
- Primary open-angle glaucoma, or secondary open-angle glaucoma (pseudoexfoliative glaucoma or pigmentary glaucoma) with indication for cataract surgery.
- Open iridocorneal angle (Shaffer classification grade 2-4)
- Early to moderate glaucoma (advanced glaucoma, with MD from VFs worse than -12dB, will be excluded)
- Presence of severe systemic pathologies 2024-A01891-46\_Protocol\_V6\_21112024\_Elios Page 20 / 58
- Pregnant or breastfeeding women
- \<18 years of age
- Presence of other ophthalmological pathologies (except cataracts), and exclusion of severe dry eye.
- History of intraocular surgery, trauma, or conjunctival scarring in the quadrant intended for surgery
- Visual acuity worse than "counting fingers".
- Closure of the iridocorneal angle (and angle-closure glaucoma), angle-closure glaucoma secondary to iridocorneal synechiae, neovascular glaucoma or neovascularization of the iris.
- Normal-pressure glaucoma
- Pachymetry \ 620 μm
- Glaucomatous visual field with mean deviation worse than ≤-12 dB
- IOP \> 35 mmHg
- Autoimmune disorder, especially collagenosis
- Patient under protective supervision
- Patient not covered by a social security scheme
The study team makes the final eligibility decision.
Where it's taking place
- Avranches, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Avranches, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.